Skip to content AMI Logo
  • Membership
    • Our community
    • Why join AMI?
    • Benefits of membership
    • Join Today
  • Scientific Advancement
    • Advisory Groups
      • Food Security
      • One Health
      • Ocean Sustainability
      • Healthy Land
      • Clean Water
      • Climate Action
    • Policy
      • Proactive Policy Work
      • Reactive Policy Work
      • Policy news
      • Policy Networks
      • Science in Parliament Magazine
    • Awards
      • Horizon Awards
      • Honorary Fellowship
  • Publishing
    • Our journals
    • The Microbiologist
  • Grants
  • Events
  • News
    • Publishing news
    • Community news
  • About us
    • Our team
      • Work for us
      • Our history
      • Brand and style guide
      • Annual reports
    • Global Ambassadors
    • Diversity & Inclusion
      • Proactive D&I Work
      • Reactive D&I Work
      • Our Networks
      • Mental health & wellbeing
    • Contact us
  • The Microbiologist
  • Login
  1. You are here:
  2. Applied Microbiology International
  3. Resource library search
  4. Executive Summary
Report/Case Study
01 May 2025

Executive Summary

Executive Summary_Bacteriophages.pdf 7.5 MB
Download

Related topics

Bacteriophages Antimicrobial resistance Global Health, One Health and Wellbeing Policy and Impact
Return to listing

You may also be interested in

img_4185_601681_crop (1).jpeg

​​​​​​​Inflammation connection could offer new targets to manage colorectal cancer

New research shared at the Minoritised Life Scientists Future Forum has uncovered a prostaglandin E2 (PGE2) connection that could offer new targets to help with managing inflammation-driven colorectal cancer (CRC).

Article
14455_651a79a0d77a4548b684683d8206e44c13_412930_crop.jpeg

Clove oil offers promise as antimicrobial alternative that could target healthcare-associated infections in low-income countries

A research study presented at MLS Future Forum has revealed that clove essential oil could offer potential as a sustainable alternative to conventional antimicrobials.

Article
AMI Diversity MLSFF.jpg

D&I Infographic 2024/25

Our 2024/25 Diversity & Inclusion Infographic sets out AMI’s current priorities, actions and commitments to building a more inclusive microbiology community. It builds on earlier statements and frameworks, and outlines key areas of focus for the year ahead.

Infographic

Applied Microbiology International is a charitable company registered in England and Wales, with charity number 1123044 and company number 06462427

Applied Microbiology International

Salisbury House,
Station Road,
Cambridge CB1 2LA

© 2025 Copyright

  • Privacy policy
  • Terms & conditions
  • Accessibility
  • Login

Design & Development by Pixl8
Membership software by ReadyMembership